This bill amends the definition of "cannabis" in the context of therapeutic use by removing "seeds" from the definition, specifically deleting references to "the seeds thereof" and "its seeds" in RSA 126-X:1, III. The revised definition now includes all parts of the Cannabis plant, excluding mature stalks, fiber, oil, and cake made from seeds, as well as sterilized seeds incapable of germination. Additionally, the bill clarifies that cannabis does not include hemp grown, processed, marketed, or sold under RSA 439-A, except as specified in RSA 126-X:8, XIX.

Furthermore, the bill allows alternative treatment centers to purchase and utilize non-intoxicating hemp cannabinoids in the production of cannabis concentrates and infused products. It mandates that all such cannabinoids and the resulting products must be tested for contaminants and cannabinoid profiles. The bill also stipulates that these centers cannot use hemp-derived products containing THC levels exceeding 0.3 percent on a dry weight basis, including any formulations of delta-8 THC, delta-9 THC, or other THC isomers. The act will take effect 60 days after its passage.

Statutes affected:
Introduced: 126-X:1, 126-X:8